Annual Total Assets
$27.35 M
-$1.90 M-6.49%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual total assets is $27.35 million, with the most recent change of -$1.90 million (-6.49%) on December 31, 2023.
- During the last 3 years, SBFM annual total assets has risen by +$26.30 million (+2515.69%).
- SBFM annual total assets is now -99.98% below its all-time high of $169.56 billion, reached on December 1, 2003.
Performance
SBFM Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$30.06 M
+$755.80 K+2.58%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly total assets is $30.06 million, with the most recent change of +$755.80 thousand (+2.58%) on September 30, 2024.
- Over the past year, SBFM quarterly total assets has increased by +$2.41 million (+8.70%).
- SBFM quarterly total assets is now -28.42% below its all-time high of $41.99 million, reached on June 1, 2022.
Performance
SBFM Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
SBFM Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | +8.7% |
| 3 y3 years | +2515.7% | +5.8% |
| 5 y5 years | +2285.1% | +5.8% |
SBFM Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +1141.4% | -28.4% | +1264.4% |
| 5 y | 5-year | -6.5% | >+9999.0% | -28.4% | >+9999.0% |
| alltime | all time | -100.0% | >+9999.0% | -28.4% | >+9999.0% |
Sunshine Biopharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.06 M(+2.6%) |
| Jun 2024 | - | $29.30 M(-8.1%) |
| Mar 2024 | - | $31.90 M(+16.6%) |
| Dec 2023 | $27.35 M(-6.5%) | $27.35 M(-1.1%) |
| Sep 2023 | - | $27.65 M(-2.7%) |
| Jun 2023 | - | $28.41 M(+5.3%) |
| Mar 2023 | - | $26.99 M(-7.7%) |
| Dec 2022 | $29.24 M(+1227.5%) | $29.24 M(-28.4%) |
| Sep 2022 | - | $40.86 M(-2.7%) |
| Jun 2022 | - | $41.99 M(+213.1%) |
| Mar 2022 | - | $13.41 M(+508.7%) |
| Dec 2021 | $2.20 M(+110.7%) | - |
| Dec 2021 | - | $2.20 M(-12.0%) |
| Sep 2021 | - | $2.50 M(+37.7%) |
| Jun 2021 | - | $1.82 M(-2.2%) |
| Mar 2021 | - | $1.86 M(+77.8%) |
| Dec 2020 | $1.05 M(+965.7%) | $1.05 M(+89.9%) |
| Sep 2020 | - | $550.50 K(+297.5%) |
| Jun 2020 | - | $138.50 K(+117.4%) |
| Mar 2020 | - | $63.70 K(-35.1%) |
| Dec 2019 | $98.10 K(-91.4%) | $98.10 K(-32.9%) |
| Sep 2019 | - | $146.30 K(+33.7%) |
| Jun 2019 | - | $109.40 K(-91.2%) |
| Mar 2019 | - | $1.25 M(+8.7%) |
| Dec 2018 | $1.15 M(+345.3%) | $1.15 M(+3.8%) |
| Sep 2018 | - | $1.10 M(-5.6%) |
| Jun 2018 | - | $1.17 M(+16.8%) |
| Mar 2018 | - | $1.00 M(+289.2%) |
| Dec 2017 | $257.50 K(+299.8%) | $257.50 K(+0.6%) |
| Sep 2017 | - | $256.00 K(+55.8%) |
| Jun 2017 | - | $164.30 K(+602.1%) |
| Mar 2017 | - | $23.40 K(-63.7%) |
| Dec 2016 | $64.40 K(-90.4%) | $64.40 K(-89.3%) |
| Sep 2016 | - | $599.30 K(-9.9%) |
| Jun 2016 | - | $665.40 K(-19.9%) |
| Mar 2016 | - | $830.60 K(+23.4%) |
| Dec 2015 | $673.30 K | $673.30 K(+392.9%) |
| Sep 2015 | - | $136.60 K(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $170.70 K(+14.8%) |
| Mar 2015 | - | $148.70 K(+3.7%) |
| Dec 2014 | $143.40 K(+359.6%) | $143.40 K(-20.5%) |
| Sep 2014 | - | $180.30 K(+308.8%) |
| Jun 2014 | - | $44.10 K(-38.6%) |
| Mar 2014 | - | $71.80 K(+130.1%) |
| Dec 2013 | $31.20 K(-76.9%) | $31.20 K(-56.4%) |
| Sep 2013 | - | $71.60 K(-55.5%) |
| Jun 2013 | - | $160.80 K(-37.9%) |
| Mar 2013 | - | $259.00 K(+92.1%) |
| Dec 2012 | $134.80 K(+26.7%) | $134.80 K(-49.7%) |
| Sep 2012 | - | $268.00 K(+145.9%) |
| Jun 2012 | - | $109.00 K(+29.5%) |
| Mar 2012 | - | $84.20 K(-20.9%) |
| Dec 2011 | $106.40 K(-48.7%) | $106.40 K(-52.5%) |
| Sep 2011 | - | $224.20 K(+57.3%) |
| Jun 2011 | - | $142.50 K(-10.5%) |
| Mar 2011 | - | $159.30 K(-23.3%) |
| Dec 2010 | $207.60 K(+85.2%) | $207.60 K(+92.0%) |
| Sep 2010 | - | $108.10 K(+563.2%) |
| Jun 2010 | - | $16.30 K(-44.0%) |
| Mar 2010 | - | $29.10 K(-83.8%) |
| Dec 2009 | $112.10 K(>+9900.0%) | - |
| Oct 2009 | - | $179.80 K(>+9900.0%) |
| Jul 2009 | $600.00(-88.0%) | $600.00(0.0%) |
| Apr 2009 | - | $600.00(-50.0%) |
| Jan 2009 | - | $1200.00(-50.0%) |
| Oct 2008 | - | $2400.00(-52.0%) |
| Jul 2008 | $5000.00(-66.4%) | $5000.00(-5.7%) |
| Apr 2008 | - | $5300.00(+8.2%) |
| Jan 2008 | - | $4900.00(-38.0%) |
| Oct 2007 | - | $7900.00 |
| Jul 2007 | $14.90 K(-100.0%) | - |
| Dec 2003 | $169.56 B(+10.5%) | - |
| Dec 2002 | $153.46 B(+37.6%) | - |
| Dec 2001 | $111.54 B(-8.9%) | - |
| Dec 2000 | $122.50 B(+7.6%) | - |
| Dec 1999 | $113.88 B(+3.5%) | - |
| Dec 1998 | $110.07 B | - |
FAQ
- What is Sunshine Biopharma annual total assets?
- What is the all time high annual total assets for Sunshine Biopharma?
- What is Sunshine Biopharma annual total assets year-on-year change?
- What is Sunshine Biopharma quarterly total assets?
- What is the all time high quarterly total assets for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total assets year-on-year change?
What is Sunshine Biopharma annual total assets?
The current annual total assets of SBFM is $27.35 M
What is the all time high annual total assets for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total assets is $169.56 B
What is Sunshine Biopharma annual total assets year-on-year change?
Over the past year, SBFM annual total assets has changed by -$1.90 M (-6.49%)
What is Sunshine Biopharma quarterly total assets?
The current quarterly total assets of SBFM is $30.06 M
What is the all time high quarterly total assets for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total assets is $41.99 M
What is Sunshine Biopharma quarterly total assets year-on-year change?
Over the past year, SBFM quarterly total assets has changed by +$2.41 M (+8.70%)